156 related articles for article (PubMed ID: 38217586)
1. The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions.
Zhang X; Wu YY; Qin YY; Lin FQ
Cancer Biomark; 2024; 39(3):223-230. PubMed ID: 38217586
[TBL] [Abstract][Full Text] [Related]
2. The association and diagnostic value of red blood cell distribution width in colorectal cancer.
Shi C; Xie M; Li L; Li K; Hu BL
Medicine (Baltimore); 2019 May; 98(19):e15560. PubMed ID: 31083220
[TBL] [Abstract][Full Text] [Related]
3. Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer.
Song Y; Huang Z; Kang Y; Lin Z; Lu P; Lin Q; Cai Z; Cao Y; Zhu X
Biomed Res Int; 2018; 2018():9858943. PubMed ID: 30643826
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
5. The value of hemoglobin-to-red blood cell distribution width ratio (Hb/RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of nasopharyngeal cancer.
Lin Z; Zhang X; Luo Y; Chen Y; Yuan Y
Medicine (Baltimore); 2021 Jul; 100(28):e26537. PubMed ID: 34260530
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological characteristics.
Zhang X; Qin H; Tan X; Mo Y; Li Z; Huang G; Wei Z
World J Surg Oncol; 2023 Jul; 21(1):200. PubMed ID: 37420210
[TBL] [Abstract][Full Text] [Related]
7. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
[TBL] [Abstract][Full Text] [Related]
8. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
[TBL] [Abstract][Full Text] [Related]
9. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract][Full Text] [Related]
10. Red Blood Cell Distribution Width (RDW) Correlates to the Anatomical Location of Colorectal Cancer. Implications for Clinical Use.
Fancellu A; Zinellu A; Mangoni AA; Popova A; Galotti F; Feo CF; Attene F; Cossu A; Palmieri G; Paliogiannis P
J Gastrointest Cancer; 2022 Jun; 53(2):259-264. PubMed ID: 33432507
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Carcinoembryonic Antigen Combined with Multi-Inflammatory Cell Ratios in Colorectal Cancer.
Liu XC; Dai YL; Huang F; Zhong ZJ; Liu XF
Dis Markers; 2022; 2022():4889616. PubMed ID: 36061352
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of matrix metalloproteinases 2, 7 and 9 in urine for early detection of colorectal cancer.
Peng L; Zhang X; Zhang ML; Jiang T; Zhang PJ
World J Gastrointest Surg; 2023 May; 15(5):931-939. PubMed ID: 37342853
[TBL] [Abstract][Full Text] [Related]
13. The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer.
Huang M; Yang Z; Ren J; Wang T; Chen D; Zhan Y; Le W; Deng S
Technol Cancer Res Treat; 2023; 22():15330338231164232. PubMed ID: 37122229
[TBL] [Abstract][Full Text] [Related]
14. A combined preoperative red cell distribution width and carcinoembryonic antigen score contribute to prognosis prediction in stage I lung adenocarcinoma.
Xu H; Zhao G; Lin J; Ye Q; Xiang J; Yan B
World J Surg Oncol; 2023 Feb; 21(1):56. PubMed ID: 36814297
[TBL] [Abstract][Full Text] [Related]
15. Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer.
Li X; Guo D; Chu L; Huang Y; Zhang F; Li W; Chen J
Cancer Manag Res; 2019; 11():9631-9640. PubMed ID: 32009818
[TBL] [Abstract][Full Text] [Related]
16. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
17. A Retrospective Study from a Single Center to Identify Hematological Factors that Distinguish Between Patients with Colorectal Carcinoma and Colorectal Adenoma.
Huang J; Xu P; Chen Y
Med Sci Monit; 2022 Aug; 28():e936745. PubMed ID: 35945827
[TBL] [Abstract][Full Text] [Related]
18. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of increased preoperative red cell distribution width (RDW) and changes in RDW for colorectal cancer.
Lu X; Huang X; Xue M; Zhong Z; Wang R; Zhang W; Wang L; Qiao Y; Ling F; Zhang Q; Zhang Y
Cancer Med; 2023 Jun; 12(12):13361-13373. PubMed ID: 37143237
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
